neostigmine has been researched along with Accelerated Idioventricular Rhythm in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Accelerated Idioventricular Rhythm: A type of automatic, not reentrant, ectopic ventricular rhythm with episodes lasting from a few seconds to a minute which usually occurs in patients with acute myocardial infarction or with DIGITALIS toxicity. The ventricular rate is faster than normal but slower than tachycardia, with an upper limit of 100 -120 beats per minute. Suppressive therapy is rarely necessary.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Accelerated idioventricular rhythm has been documented in several cases involving the induction of general anesthesia; however, it has not previously been known to occur during reversal of neuromuscular blockade with neostigmine and glycopyrrolate." | 4.12 | New-Onset Accelerated Idioventricular Rhythm During Dental Rehabilitation. ( Bartlett, HL; Rizner, JD; Shaw, RE, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rizner, JD | 1 |
| Bartlett, HL | 1 |
| Shaw, RE | 1 |
1 other study available for neostigmine and Accelerated Idioventricular Rhythm
| Article | Year |
|---|---|
New-Onset Accelerated Idioventricular Rhythm During Dental Rehabilitation.
Topics: Accelerated Idioventricular Rhythm; Child; Glycopyrrolate; Humans; Male; Neostigmine | 2022 |